Page last updated: 2024-11-06

resorufin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Resorufin is a fluorescent dye commonly used in research. It is synthesized by oxidation of resorcinol, a phenolic compound. Resorufin is a substrate for various enzymes, such as cytochrome P450, and its fluorescence can be used to monitor enzyme activity. It is also used as a probe for cellular redox status and as a marker for cell viability. Resorufin's bright fluorescence and its ability to be easily detected make it a valuable tool in various research fields, including biochemistry, cell biology, and pharmacology.'

Cross-References

ID SourceID
PubMed CID69462
CHEMBL ID1185321
CHEBI ID51602
SCHEMBL ID8066
MeSH IDM0062502

Synonyms (41)

Synonym
CHEBI:51602 ,
nsc 12097
brn 0174850
einecs 211-241-8
7-hydroxyphenoxazin-3-one
resorufin
635-78-9
3h-phenoxazin-3-one, 7-hydroxy-
nsc12097 ,
resorufine
nsc-12097
BCBCMAP01_000141
7-hydroxy-3h-phenoxazin-3-one
SMP1_000256
resorufin, dye content 95 %
NCI60_000493
R0012
a3nus7k96s ,
unii-a3nus7k96s
4-27-00-02263 (beilstein handbook reference)
CHEMBL1185321
CCG-36357
AKOS015916378
SCHEMBL8066
DTXSID3060906
7-hydroxy-3h-phenoxazin-3-one #
hydroxyphenazone
mfcd00128991
resorufin, 95%
us9216974,resorufin
bdbm195591
T72749
resorufin, high purity standard
Q27122674
FS-5650
EN300-197431
HY-123533
CS-0082928
A937219
Z1513803227
SY052550

Research Excerpts

Overview

Resorufin acetate is a good substrate for sheep liver cytosolic aldehyde dehydrogenase. It provides information about the nature of the catalysis shown by this enzyme.

ExcerptReferenceRelevance
"Resorufin is a marker dye that is widely used in different fields of microbiology and has increasingly been applied in droplet microfluidic assays and experiments."( Dodecylresorufin (C12R) Outperforms Resorufin in Microdroplet Bacterial Assays.
Garstecki, P; Kaminski, TS; Ruszczak, A; Scheler, O, 2016
)
1.61
"Resorufin acetate is a very good substrate for sheep liver cytosolic aldehyde dehydrogenase, both from the point of view of practical spectrophotometry and in terms of information provided about the nature of the catalysis shown by this enzyme. "( Studies of the esterase activity of cytosolic aldehyde dehydrogenase with resorufin acetate as substrate.
Kitson, KE; Kitson, TM, 1997
)
1.97

Effects

ExcerptReferenceRelevance
"Resorufin (1) has been found to act as an electron acceptor in glucose oxidase (GOD)-catalyzed oxidation of glucose. "( Resorufin as an electron acceptor in glucose oxidase-catalyzed oxidation of glucose.
Maeda, H; Matsu-ura, S; Ohmori, H; Senba, T; Takai, H; Yamasaki, S; Yamauchi, Y, 2000
)
3.19

Toxicity

ExcerptReferenceRelevance
" The aim was to develop a test system that was capable of examining both genotoxicity and cytotoxicity on the basis of the metabolic health of the cells so as to provide a better assessment of the negative influence of toxic effects on the evaluation of genotoxicity."( Modification of the umu-assay (ISO 13829) accounting for cytotoxicity in genotoxicity assessment: a preliminary study.
Ahlf, W; Gutiérrez, IR; Toolaram, AP, 2012
)
0.38
" faecalis, a Gram-positive and facultative anaerobic bacterial strain, and the most toxic chlorophenol, pentachlorophenol (PCP), were chosen as models for an anaerobe and toxicant, respectively."( Metabolic reduction of resazurin; location within the cell for cytotoxicity assays.
Chen, JL; Steele, TWJ; Stuckey, DC, 2018
)
0.48

Compound-Compound Interactions

ExcerptReferenceRelevance
" The technique selectively recognizes resorufin using on-chip screening in combination with an in silico evolution method."( DNA aptamers that recognize fluorophore using on-chip screening in combination with an in silico evolution.
Asai, R; Nishimura, SI; Takahashi, K, 2003
)
0.59

Bioavailability

ExcerptReferenceRelevance
" Decreased bioavailability of nitric oxide, a condition known as "endothelial dysfunction," is considered an early step in this process before atherosclerotic changes of the vessel wall occur."( Modulation of Vascular Function by AMPK: Assessment of NO Bioavailability and Surrogates of Oxidative Stress.
Daiber, A; Kröller-Schön, S; Schulz, E, 2018
)
0.48
" We studied whether glucocorticoid receptor (GR) silencing or inhibition in human epileptic brain endothelial cells (EPI-ECs) functionally impacts drug bioavailability across an in vitro model of the blood-brain barrier (BBB) by CYP-multidrug transporter (multidrug resistance protein 1, MDR1) mechanisms."( Modulation of glucocorticoid receptor in human epileptic endothelial cells impacts drug biotransformation in an in vitro blood-brain barrier model.
Bingaman, W; Ghosh, C; Gonzalez-Martinez, J; Hossain, M; Janigro, D; Khan, S; Marchi, N; Mishra, S; Najm, I, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" Dose-response studies demonstrated that curcumin concentrations of >or=25 micro M were cytotoxic for oral SCC cells."( Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa.
Fields, HW; Mallery, SR; Morse, MA; Pei, P; Renner, RJ; Rinaldi, AL; Rodrigo, KA; Rothas, DA, 2002
)
0.31
" These results might suggest that CYP2D and 3A substrates should be prescribed for male and female cats using different dosage regimen."( Characterization of cytochrome P450-mediated drug metabolism in cats.
Regmi, NL; Sanda, S; Sasaki, K; Shah, SS; Shimoda, M, 2007
)
0.34
" The use of the BMD(T) implies a focus on the change of structure in the parameter's dose-response rather than a particular percentage change in the response in such a parameter."( The point of transition on the dose-effect curve as a reference point in the evaluation of in vitro toxicity data.
Håkansson, H; Öberg, M; Ringblom, J; Sand, S, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenoxazine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (269)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (7.81)18.7374
1990's41 (15.24)18.2507
2000's77 (28.62)29.6817
2010's111 (41.26)24.3611
2020's19 (7.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.62 (24.57)
Research Supply Index5.63 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index66.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other275 (98.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]